Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Cash & Current Investments: 2009-2024

Historic Cash & Current Investments for Rockwell Medical (RMTI) over the last 16 years, with Dec 2024 value amounting to $21.6 million.

  • Rockwell Medical's Cash & Current Investments rose 29.74% to $23.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $81.1 million, marking a year-over-year increase of 63.14%. This contributed to the annual value of $21.6 million for FY2024, which is 97.55% up from last year.
  • Rockwell Medical's Cash & Current Investments amounted to $21.6 million in FY2024, which was up 97.55% from $10.9 million recorded in FY2023.
  • Over the past 5 years, Rockwell Medical's Cash & Current Investments peaked at $58.7 million during FY2020, and registered a low of $10.9 million during FY2023.
  • Over the past 3 years, Rockwell Medical's median Cash & Current Investments value was $21.5 million (recorded in 2022), while the average stood at $18.0 million.
  • In the last 5 years, Rockwell Medical's Cash & Current Investments spiked by 125.30% in 2020 and then slumped by 61.76% in 2021.
  • Rockwell Medical's Cash & Current Investments (Yearly) stood at $58.7 million in 2020, then crashed by 61.76% to $22.4 million in 2021, then declined by 4.22% to $21.5 million in 2022, then crashed by 49.12% to $10.9 million in 2023, then spiked by 97.55% to $21.6 million in 2024.